The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation
Abstract
Donor organ shortages for transplantation remain a serious global concern, and alternative treatment is in high demand. Fetal cells and tissues have considerable therapeutic potential as, for example, organoid technology that uses human induced pluripotent stem cells (hiPSCs) to generate unlimited human fetal-like cells and tissues. We previously reported the in vivo vascularization of early fetal liver–like hiPSC-derived liver buds (LBs) and subsquent improved survival of recipient mice with subacute liver failure. Here, we show hiPSC–liver organoids (LOs) that recapitulate midgestational fetal liver promote de novo liver generation when grafted onto the surface of host livers in chemical fibrosis models, thereby recovering liver function. We found that fetal liver, a hematopoietic tissue, highly expressed macrophage-recruiting factors and antifibrotic M2 macrophage polarization factors compared with the adult liver, resulting in fibrosis reduction because of CD163 + M2-macrophage polarization. Next, we created midgestational fetal liver–like hiPSC-LOs by fusion of hiPSC-LBs to induce static cell-cell interactions and found that these contained complex structures such as hepatocytes, vasculature, and bile ducts after transplantation. This fusion allowed the generation of a large human tissue suitable for transplantation into immunodeficient rodent models of liver fibrosis. hiPSC-LOs showed superior liver function compared with hiPSC-LBs and improved survival and liver function upon transplantation. In addition, hiPSC-LO transplantation ameliorated chemically induced liver fibrosis, a symptom of liver cirrhosis that leads to organ dysfunction, through immunomodulatory effects, particularly on CD163 + phagocytic M2-macrophage polarization. Together, our results suggest hiPSC-LO transplantation as a promising therapeutic option for liver fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S.-I., Kitamura, Y., Yoshida, N., Kikutani, H., & Kishimoto, T. (1996) · Nature · doi:10.1038/382635a0 · Cited by 2,338
Vascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170 · cited 1×
“Previously, we generated hiPSC–liver buds (LBs) by mimicking the process of early liver development ( 5 , 8 ).”
MethodSelf-citationA phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis
Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2309000 · Cited by 2,084
Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro
Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle, K., Hoskins, E. E., Kalinichenko, V. V., Wells, S. I., Zorn, A. M., et al. (2011) · Nature · doi:10.1038/nature09691 · Cited by 1,922
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Stem Cell Therapies in Clinical Trials: Progress and Challenges
Trounson, A., & McDonald, C. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.06.007 · Cited by 1,468
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
Hoeffel, G., Chen, J., Lavin, Y., Low, D., Almeida, F. F., See, P., Beaudin, A. E., Lum, J., Low, I., Forsberg, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.011 · Cited by 1,135 · cited 1×
“In the developing liver, stellate cells and ECs express the MF-recruiting factor CSF1, resulting in the influx of yolk sac–derived MFs followed by gradual replacement with monocyte-derived MFs ( 17 , 42 ).”
BackgroundHuman cerebral organoids recapitulate gene expression programs of fetal neocortex development
Camp, J. G., Badsha, F., Florio, M., Kanton, S., Gerber, T., Wilsch-Bräuninger, M., Lewitus, E., Sykes, A., Hevers, W., Lancaster, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520760112 · Cited by 1,130
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055 · cited 1×
“MFs are classified into M1-MFs and M2-MFs; M1-MFs induce inflammation, thereby promoting tissue injury, whereas M2-MFs, which are activated as part of the type 2 immunity regulated by interleukin-4 (IL-4)/IL-13, have anti-inflammatory effects and are involved in tissue repair ( 26 ).”
BackgroundRamachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001 · cited 1×
“During the recovery phase, MFs express anti-inflammatory factors and matrix metalloproteases (MMPs) that degrade collagen fibers and repair liver fibrosis ( 21 , 22 ).”
BackgroundAbnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Specification of tissue-resident macrophages during organogenesis
Mass, E., Ballesteros, I., Farlik, M., Halbritter, F., Günther, P., Crozet, L., Jacome-Galarza, C. E., Händler, K., Klughammer, J., Kobayashi, Y., et al. (2016) · Science · doi:10.1126/science.aaf4238 · Cited by 891 · cited 2×
“MFs in the fetal liver exhibit characteristics resembling those of M2-MFs, indicating that fetal liver tissue can maintain an M2-MF–rich microenvironment by exerting immuno-modulatory functions ( 19 , 31 , 32 ).”
BackgroundLiver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function
Matsumoto, K., Yoshitomi, H., Rossant, J., & Zaret, K. S. (2001) · Science · doi:10.1126/science.1063889 · Cited by 875
In vitro generation of human pluripotent stem cell derived lung organoids
Dye, B. R., Hill, D. R., Ferguson, M. A., Tsai, Y.-H., Nagy, M. S., Dyal, R., Wells, J. M., Mayhew, C. N., Nattiv, R., Klein, O. D., et al. (2015) · eLife · doi:10.7554/elife.05098 · Cited by 819
Xiong, X., Kuang, H., Ansari, S., Liu, T., Gong, J., Wang, S., Zhao, X.-Y., Ji, Y., Li, C., Guo, L., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.028 · Cited by 784
Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver
Wang, B., Zhao, L., Fish, M., Logan, C. Y., & Nusse, R. (2015) · Nature · doi:10.1038/nature14863 · Cited by 674
Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., Morizane, A., Doi, D., Takahashi, J., Nishizawa, M., et al. (2014) · Scientific Reports · doi:10.1038/srep03594 · Cited by 673
Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
Chávez-Galán, L., Olleros, M. L., Vesin, D., & Garcia, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00263 · Cited by 653
Bonnardel, J., T’Jonck, W., Gaublomme, D., Browaeys, R., Scott, C. L., Martens, L., Vanneste, B., De Prijck, S., Nedospasov, S. A., Kremer, A., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.017 · Cited by 631 · cited 2×
“In addition, because the embryonic liver is a site of hematopoiesis, there are cell-cell interactions be-tween hematopoietic cells and liver parenchymal/nonparenchymal cells ( 13 – 18 , 42 , 46 , 47 ).”
BackgroundMultilineage communication regulates human liver bud development from pluripotency
Camp, J. G., Sekine, K., Gerber, T., Loeffler-Wirth, H., Binder, H., Gac, M., Kanton, S., Kageyama, J., Damm, G., Seehofer, D., et al. (2017) · Nature · doi:10.1038/nature22796 · Cited by 621 · cited 2×
“To apply the mechanisms of fetal-stage organogenesis to regenerative therapies for adult diseases, the focus should be on cell-cell interactions in the embryonic organ, which activate various signaling pathways related to cell differentiation and angiogenesis ( 10 – 12 ).”
BackgroundSelf-citationLoomba, R., Abdelmalek, M. F., Armstrong, M. J., Jara, M., Kjær, M. S., Krarup, N., Lawitz, E., Ratziu, V., Sanyal, A. J., Schattenberg, J. M., et al. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00068-7 · Cited by 533
Lyman, S. D., James, L., Bos, T. V., de Vries, P., Brasel, K., Gliniak, B., Hollingsworth, L. T., Picha, K. S., McKenna, H. J., Splett, R. R., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90325-k · Cited by 527
Regulatory phases of early liver development: paradigms of organogenesis
Zaret, K. S. (2002) · Nature Reviews Genetics · doi:10.1038/nrg837 · Cited by 508
Fallowfield, J. A., Mizuno, M., Kendall, T. J., Constandinou, C. M., Benyon, R. C., Duffield, J. S., & Iredale, J. P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5288 · Cited by 479
Kamiya, A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2127 · Cited by 427
Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells
Takebe, T., Sekine, K., Kimura, M., Yoshizawa, E., Ayano, S., Koido, M., Funayama, S., Nakanishi, N., Hisai, T., Kobayashi, T., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.005 · Cited by 403
Self-citationAra, T., Tokoyoda, K., Sugiyama, T., Egawa, T., Kawabata, K., & Nagasawa, T. (2003) · Immunity · doi:10.1016/s1074-7613(03)00201-2 · Cited by 369
Long-term Clinical Outcome of Fetal Cell Transplantation for Parkinson Disease: Two Case Reports
Kefalopoulou, Z., Politis, M., Piccini, P., Mencacci, N., Bhatia, K., Jahanshahi, M., Widner, H., Rehncrona, S., Brundin, P., Björklund, A., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4749 · Cited by 300
Tremblay, K. D., & Zaret, K. S. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.01.003 · Cited by 299
Tanimizu, N., & Miyajima, A. (2004) · Journal of Cell Science · doi:10.1242/jcs.01169 · Cited by 291
Self-citationHofmann, J. J., Zovein, A. C., Koh, H., Radtke, F., Weinmaster, G., & Iruela-Arispe, M. L. (2010) · Development · doi:10.1242/dev.052118 · Cited by 249
Mouy, R., Stephan, J.-L., Pillet, P., Haddad, E., Hubert, P., & Prieur, A.-M. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70160-9 · Cited by 244
Fetal liver hematopoietic stem cell niches associate with portal vessels
Khan, J. A., Mendelson, A., Kunisaki, Y., Birbrair, A., Kou, Y., Arnal-Estapé, A., Pinho, S., Ciero, P., Nakahara, F., Ma’ayan, A., et al. (2016) · Science · doi:10.1126/science.aad0084 · Cited by 241
Hendrikx, T., Porsch, F., Kiss, M. G., Rajcic, D., Papac-Miličević, N., Hoebinger, C., Goederle, L., Hladik, A., Shaw, L. E., Horstmann, H., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.004 · Cited by 220
Safety profile of autologous macrophage therapy for liver cirrhosis
Moroni, F., Dwyer, B. J., Graham, C., Pass, C., Bailey, L., Ritchie, L., Mitchell, D., Glover, A., Laurie, A., Doig, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0599-8 · Cited by 202
Han, L., Chaturvedi, P., Kishimoto, K., Koike, H., Nasr, T., Iwasawa, K., Giesbrecht, K., Witcher, P. C., Eicher, A., Haines, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17968-x · Cited by 182
Macrophage-derived osteopontin (SPP1) protects from nonalcoholic steatohepatitis
Han, H., Ge, X., Komakula, S. S. B., Desert, R., Das, S., Song, Z., Chen, W., Athavale, D., Gaskell, H., Lantvit, D., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.228 · Cited by 155
Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells
Chou, S., & Lodish, H. (2010) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1003586107 · Cited by 141
Segal, J. M., Kent, D., Wesche, D. J., Ng, S. S., Serra, M. P., Oulès, B., Kar, G., Emerton, G., Blackford, S. J. I., Darmanis, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11266-x · Cited by 132
Temporal analyses of postnatal liver development and maturation by single-cell transcriptomics
Liang, Y., Kaneko, K., Xin, B., Lee, J., Sun, X., Zhang, K., & Feng, G.-S. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.01.004 · Cited by 116
Fetal stem cell transplantation: Past, present, and future
Ishii, T. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i4.404 · Cited by 98
Tanigawa, S., Tanaka, E., Miike, K., Ohmori, T., Inoue, D., Cai, C., Taguchi, A., Kobayashi, A., & Nishinakamura, R. (2022) · Nature Communications · doi:10.1038/s41467-022-28226-7 · Cited by 92
Characterization and Functional Analyses of Hepatic Mesothelial Cells in Mouse Liver Development
Onitsuka, I., Tanaka, M., & Miyajima, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.059 · Cited by 80
Self-citationDual role of Mpl receptor during the establishment of definitive hematopoiesis
Petit, L., Volle‐Challier, C., Fleury, M., Péault, B., & Souyri, M. (2007) · Development · doi:10.1242/dev.001818 · Cited by 72
Human Induced Pluripotent Stem Cell-Derived Macrophages Ameliorate Liver Fibrosis
Pouyanfard, S., Meshgin, N., Cruz, L. S., Diggle, K., Hashemi, H., Pham, T. V., Fierro, M., Tamayo, P., Fanjul, A. N., Kisseleva, T., et al. (2021) · Stem Cells · doi:10.1002/stem.3449 · Cited by 64
Klimchenko, O., Stefano, A. D., Geoerger, B., Hamidi, S., Opolon, P., Robert, T., Routhier, M., Benna, J. E., Delezoide, A., Boukour, S., et al. (2010) · Blood · doi:10.1182/blood-2010-07-295246 · Cited by 54
Walter, T. J., Cast, A. E., Huppert, K. A., & Huppert, S. S. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00426.2013 · Cited by 54
Moore, J. K., MacKinnon, A. C., Wojtacha, D., Pope, C., Fraser, A. R., Burgoyne, P., Bailey, L., Pass, C., Atkinson, A. P. M., McGowan, N. W. A., et al. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.07.016 · Cited by 54
Crosstalk Between the Hepatic and Hematopoietic Systems During Embryonic Development
Soares-da-Silva, F., Peixoto, M., Cumano, A., & Pinto-do-Ó, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00612 · Cited by 36
Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis
Jaganathan, D., Bruscia, E. M., & Kopp, B. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147750 · Cited by 20
Infusion of Phagocytic Macrophages Overexpressing CPT1a Ameliorates Kidney Fibrosis in the UUO Model
Calle, P., Játiva, S., Torrico, S., Muñoz, A., García, M., Solà, A., Serra, D., Mera, P., Herrero, L., & Hotter, G. (2021) · Cells · doi:10.3390/cells10071650 · Cited by 13
Kawakatsu-Hatada, Y., Murata, S., Mori, A., Kimura, K., & Taniguchi, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111589 · Cited by 4
Self-citation
Cited by
Wang, J., Zhan, H., Wang, Y., Zhao, L., Huang, Y., & Wu, R. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03989-6 · Cited by 33
Organoids for tissue repair and regeneration
Yu, B., Zhou, D., Wang, F., Chen, X., Li, M., & Su, J. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102013 · Cited by 40
Remodeling of senescent macrophages in synovium alleviates trauma- and aging-induced osteoarthritis
Liu, Y., Duan, J., Dang, Y., Hao, R., Wang, H., Tan, E., Wang, R., Li, Y., Zhang, S., Wang, Y., et al. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.09.016 · Cited by 42
Panferov, E., Dodina, M., Reshetnikov, V. V., Ryapolova, A., Ivanov, R. A., Karabelsky, A. V., & Minskaia, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125617 · Cited by 28
Advances in liver and pancreas organoids: how far we have come and where we go next
Sljukic, A., Jenkinson, J. G., Niksic, A., Prior, N., & Huch, M. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01116-1 · Cited by 26
Metadata
- Authors
- Tadokoro, T., Murata, S., Kato, M., Ueno, Y., Tsuchida, T., Okumura, A., Kuse, Y., Konno, T., Uchida, Y., Yamakawa, Y., Zushi, M., Yajima, M., Kobayashi, T., Hasegawa, S., Kawakatsu-Hatada, Y., Hayashi, Y., Osakabe, S., Maeda, T., Kimura, K., Mori, A., Tanaka, M., Kamishibahara, Y., Matsuo, M., Nie, Y.-Z., Okamoto, S., Oba, T., Tanimizu, N., & Taniguchi, H.
- Affiliations
- Institute of Medical Science, The University of Tokyo (JP)
- Yokohama City University (JP)
- Department of Regenerative Medicine, Yokohama City University School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
- Corresponding author
- Tadokoro, Tomomi
- Taniguchi, Hideki
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2024-07-24
- Volume
- 16
- Issue
- 757
- Pages
- eadg0338-eadg0338
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4400945382
- Cited by
- 58
- References
- 54
- Citations by year
- 2026: 24 · 2025: 31 · 2024: 3
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23K08053, 22K08807)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- human induced pluripotent stem cells, liver organoids, liver fibrosis, liver transplantation, M2 macrophage polarization, CD163, immunomodulation, cell fusion, liver cirrhosis, hepatocyte differentiation, vascularization
- MeSH terms
- Animals, Humans, Liver, Liver Cirrhosis, Macrophages, Organoids, Liver Transplantation, Mice, Immunomodulation, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.